Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Should you use your smartwatch or wearable to monitor your heart?

Should you use your smartwatch or wearable to monitor your heart?

Date time 9 November, 2022
News Type News type Research News
Dr Jessica Orchard, Associate Faculty member at the Centenary Institute, together with Professor Ben Freedman from the Heart Research Institute, have written an article for The Conversation on wearable technologies and heart health.

The article was based on a review published in the science journal Circulation, weighing up the current evidence and exploring the complexities involved in consumer-led screening for atrial fibrillation.

In the article they explore the issues and complexities involved in the use of wearables and other portable consumer devices to screen for atrial fibrillation – an irregular rhythm that can lead to strokes. Opportunistic screening for atrial fibrillation for people 65 years and over is currently recommended by Australian Heart Foundation guidelines.

The authors suggest that wearables have many benefits for consumers, who can record their own heart rhythms whenever they wish. They are also very useful as an ‘event monitor’ for anyone with symptoms. The technology can empower consumers and provide important heart information, but it does have limitations.

“Wearables can be useful for helping people to get an early diagnosis of atrial fibrillation. Some of the devices are very accurate – often over 95%,” said Dr Orchard.

“However, device manufacturers often don’t publish many details about the accuracy and performance of their devices in different populations, and even highly accurate devices, can and do give false positives. You will still need to see a doctor to confirm a diagnosis.”

Dr Orchard also says that many people who buy wearables are younger which is an added complication in determining management.

“We aren’t yet sure about what it means when a young person with few or no risk factors has a short episode of atrial fibrillation. Medical research in this area is still ongoing,” she said.

Overall says Dr Orchard, wearable heart monitoring technology is here to stay. We just have to make sure we understand the benefits and limitations.

Themes

  • Cardiovascular Research

    Cardiovascular Research

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • New grant targets longer-lasting islet cell treatments for type 1 diabetes

    Dr Lise Hunault, a researcher in the Centenary Institute’s Centre for Biomedical AI, has been awarded a major research grant from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organisation, to advance islet-cell replacement therapies for type 1 diabetes.
    News Type: Research News
    Date 16 Mar 2026
  • Centenary marks International Women’s Day with inspiring speakers

    The Centenary Institute community came together to celebrate International Women’s Day 2026, with a special event highlighting this year’s Australian theme, ‘Balancing the Scales.’
    News Type: Community
    Date 11 Mar 2026
  • Vaxosome launched to develop next-generation mRNA vaccines

    A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.
    News Type: Research News
    Date 10 Mar 2026
  • Centenary partners in transformative national liver health program

    The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.
    News Type: Research News
    Date 05 Mar 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram